Current uses of isolated limb perfusion in the clinic and a model system for new strategies (Q33187671)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article

Language	Label	Description	Also known as
English	Current uses of isolated limb perfusion in the clinic and a model system for new strategies	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

1 reference

Europe PubMed Central

Current uses of isolated limb perfusion in the clinic and a model system for new strategies (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Alexander M. M. Eggermont

1

object named as

Alexander M M Eggermont

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Johannes H.W. de Wilt

2

object named as

Johannes H W de Wilt

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

author name string

Timo L M ten Hagen

3

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

publication date

1 July 2003

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Lancet Oncology Commission

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

429-437

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Chemotherapy of cancer: regional perfusion utilizing an extracorporeal circuit

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901141-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Isolated limb perfusion for melanoma: effectiveness and toxicity of cisplatin compared with that of melphalan and other drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901141-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Systemic leakage during isolated limb perfusion for melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901141-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901141-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Optimization of isolated hyperthermic limb perfusion

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901141-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Selective heat sensitivity of cancer cells. Biochemical and clinical studies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901141-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Melphalan uptake, hyperthermic synergism and drug resistance in a human cell culture model for the isolated limb perfusion of melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901141-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A retrospective comparative study evaluating the results of a single-perfusion versus double-perfusion schedule with melphalan in patients with recurrent melanoma of the lower limb

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901141-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Objective regression of unexcised melanoma in-transit metastases after hyperthermic isolation perfusion of the limbs with melphalan

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901141-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A clinical and pharmacokinetic study of isolated limb perfusion with heat and melphalan for melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901141-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperthermic isolated perfusion with melphalan in the treatment of advanced malignant melanoma of the lower limb

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901141-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A retrospective comparative study evaluating the results of mild hyperthermic versus controlled normothermic perfusion for recurrent melanoma of the extremities

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901141-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperthermic antiblastic perfusion in the treatment of cancer of the extremities.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901141-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Value of therapeutic hyperthermic limb perfusion in advanced recurrent melanoma of the lower extremity.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901141-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperthermic isolated limb perfusion for malignant melanoma: Response and survival

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901141-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic variables in recurrent limb melanoma treated with hyperthermic antiblastic perfusion

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901141-0

7 January 2021

based on heuristic

inferred from DOI database lookup

An endotoxin-induced serum factor that causes necrosis of tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901141-0

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901141-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Regional therapy of melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901141-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-dose tumour necrosis factor alpha and melphalan in hyperthermic isolated limb perfusion

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901141-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of primary or relapsing limb cancer by isolation perfusion with high-dose alpha-tumor necrosis factor, gamma-interferon, and melphalan

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901141-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of patients with melanoma of the extremity using hyperthermic isolated limb perfusion with melphalan, tumor necrosis factor, and interferon gamma: results of a tumor necrosis factor dose-escalation study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901141-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Isolated limb perfusion with tumour necrosis factor-alpha and melphalan with or without interferon-gamma for the treatment of in-transit melanoma metastases: a multicentre randomized phase II study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901141-0

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo anti-tumour activity of recombinant human and murine TNF, alone and in combination with murine IFN-gamma, on a syngeneic murine melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901141-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Isolated limb reperfusion with tumor necrosis factor and melphalan in patients with extremity melanoma after failure of isolated limb perfusion with chemotherapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901141-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Prophylactic isolation-perfusion as the primary therapy for invasive malignant melanoma of the limbs

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901141-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities. Swedish Melanoma Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901141-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy of Sarcomas of the Limbs by Regional Perfusion

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901141-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Regional perfusion for malignant melanoma and soft tissue sarcoma: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901141-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics, toxicity, and short-term results of cisplatin hyperthermic isolated limb perfusion for soft-tissue sarcoma and melanoma of the extremities

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901141-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of regional isolation perfusion with cytostatics in patients with soft tissue tumors of the extremities

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901141-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study on neoadjuvant hyperthermic-antiblastic perfusion with doxorubicin in patients with intermediate or high grade limb sarcomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901141-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901141-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of recurrent sarcoma of the extremities by isolated limb perfusion using tumor necrosis factor alpha and melphalan.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901141-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901141-0

7 January 2021

based on heuristic

inferred from DOI database lookup

High dose tumor necrosis factor-alpha and melphalan administered via isolated limb perfusion for advanced limb soft tissue sarcoma results in a >90% response rate and limb preservation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901141-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Soft tissue limb sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901141-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Limb salvage by neoadjuvant isolated perfusion with TNFalpha and melphalan for non-resectable soft tissue sarcoma of the extremities

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901141-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Isolated limb perfusion with tumor necrosis factor and melphalan for nonresectable sSewart-Treves lymphangiosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901141-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Fifty tumor necrosis factor-based isolated limb perfusions for limb salvage in patients older than 75 years with limb-threatening soft tissue sarcomas and other extremity tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901141-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Regional toxicity after isolated limb perfusion with melphalan and tumour necrosis factor- alpha versus toxicity after melphalan alone

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901141-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperthermic isolated limb perfusion with tumor necrosis factor alpha, interferon gamma, and melphalan for locally advanced nonmelanoma skin tumors of the extremities: a multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901141-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Isolated limb perfusion with tumour necrosis factor-alpha and melphalan for unresectable bone sarcomas of the lower extremity

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901141-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Limb desmoid tumors: a possible role for isolated limb perfusion with tumor necrosis factor-alpha and melphalan

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901141-0

7 January 2021

based on heuristic

inferred from DOI database lookup

31P magnetic resonance spectroscopy as predictor of clinical response in human extremity sarcomas treated by single dose TNF-alpha + melphalan isolated limb perfusion

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901141-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Early endothelium activation and polymorphonuclear cell invasion precede specific necrosis of human melanoma and sarcoma treated by intravascular high-dose tumour necrosis factor alpha (rTNF alpha)

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901141-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Synergistic antitumour effect of recombinant human tumour necrosis factor alpha with melphalan in isolated limb perfusion in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901141-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Isolated limb perfusion with TNF alpha and melphalan in a rat osteosarcoma model: a new anti-tumour approach

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901141-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumour necrosis factor alpha increases melphalan concentration in tumour tissue after isolated limb perfusion

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901141-0

7 January 2021

based on heuristic

inferred from DOI database lookup

TNF-alpha augments intratumoural concentrations of doxorubicin in TNF-alpha-based isolated limb perfusion in rat sarcoma models and enhances anti-tumour effects

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901141-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction of interstitial fluid pressure after TNF-alpha treatment of three human melanoma xenografts

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901141-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of the role of neutrophils on the antitumor effect of TNFalpha in an in vivo isolated limb perfusion model in sarcoma-bearing brown Norway rats

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901141-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Nitric oxide synthase inhibition results in synergistic anti-tumour activity with melphalan and tumour necrosis factor alpha-based isolated limb perfusions

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901141-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Isolated limb perfusion for local gene delivery: efficient and targeted adenovirus-mediated gene transfer into soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901141-0

7 January 2021

based on heuristic

inferred from DOI database lookup

TNF is here to stay--revisited

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901141-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(03)01141-0

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

release_mcqyg4uzwjgcfffqyepyz2mwje

1 reference

https://api.fatcat.wiki/v0/release/mcqyg4uzwjgcfffqyepyz2mwje

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33187671&oldid=2265437141"